Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-27T22:19:59.666Z Has data issue: false hasContentIssue false

Introduction: Access to Life-Saving Medicines and Intellectual Property Rights

Published online by Cambridge University Press:  25 March 2011

Extract

As the authors of the Millennium Development Goals (MDG) Gap Task Force have noted, access to medicines is a vital component of realizing the human right to health. Without reliable access to drugs, the highest attainable standard of health cannot be achieved.

Type
Symposium on Global Bioethics
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. United Nations MDG Gap Task Force. Delivering on the Global Partnership for Achieving the Millennium Development Goals, 2008; available at http://www.who.int/medicines/mdg/MDG8EnglishWeb.pdf, page 42 (last accessed 31 Jul 2010).Google Scholar

2. Templeton, SK.Banned cancer drugs better than NHS ones. The Sunday Times; available at http://www.timesonline.co.uk/tol/life_and_style/health/article4138237.ece (last accessed 31 Jul 2010).Google Scholar

3. Smith, R.Sutent for kidney cancer approved on NHS but other drugs turned down. Telegraph; available at http://www.telegraph.co.uk/health/healthnews/6087834/Sutent-for-kidney-cancer-approved-on-NHS-but-other-drugs-turned-down.html (last accessed 31 Jul 2010).Google Scholar

4. World Health Organization. Tuberculosis; available at http://www.who.int/mediacentre/factsheets/fs104/en/ (last accessed 31 Jul 2010).

5. Grover, A.Promotion and Protection of all Human Rights, Civil, Political, Economic, Social and Cultural Rights, including the Right to Development, a Report of the Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health, 2009, United Nations, A/HRC/11/12, p.6, 7, 28, available at http://www2.ohchr.org/english/bodies/hrcouncil/docs/11session/A.HRC.11.12_en.pdf (last accessed 31 Jul 2010).Google Scholar

6. Selgelid, M, Sepers, EM. Patents, profits, and the price of pills: Implications for access and availability. In: Illingworth, P, Schuklenk, U, Cohen, JC, eds. The Power of Pills: Social, Ethical and Legal Issues in Drug Development, Marketing and Pricing Policies. London: Pluto Press; 2006:153–63.Google Scholar